Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measuring Immunity Against Circulating Influenza Viruses: Randomized Immunogenicity Study Among US Adults Aged 18-64 Years Comparing Two Approved Influenza Vaccines

NCT06518577 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT06518577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06518577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measuring Immunity Against Circulating Influenza Viruses: Randomized Immunogenicity Study Among US Adults Aged 18-64 Years Comparing Two Approved Influenza Vaccines
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
September 9, 2024
Completion date
June 4, 2025
Enrollment
606 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

influenza